Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.41 |
| ▸ | ACE | P12821 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29741342 | 1.00 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL787393 | 1.00 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL5869685 | 0.94 | FOLH1 (0.45) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL8254457 | 0.94 | FOLH1 (0.45) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL3727817 | 0.87 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL209237 | 0.87 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL1413149 | 0.87 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| Leucine SCHEMBL8340593 | 0.87 | SLC7A5 (0.50) | FOLH1GSRSLC6A5CPB2 | |
| SCHEMBL10939912 | 0.86 | FOLH1 (0.46) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL23451044 | 0.85 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12044684-B2 | Methods for diagnosing an autistic spectrum disorder | QATAR UNIVERSITY (QA) | 2024-07-23 | — | — | US | claimed |
| CN-114624362-A | Kit for detecting advanced glycosylation end products in serum and application thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2022-06-14 | — | — | CN | claimed |
| CN-117384766-A | Aspergillus amsterdam S01 and application thereof | 商洛学院 | 2024-01-12 | — | — | CN | disclosed |
| WO-2024005358-A1 | ZEBRAFISH ANIMAL MODEL FOR INFLAMMATORY DISEASES AND METHOD FOR SCREENING ANTI-INFLAMMATORY AGENTS USING SAME | (주)레이델코리아 | 2024-01-04 | — | — | WO | disclosed |
| CN-114624362-A | Kit for detecting advanced glycosylation end products in serum and application thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2022-06-14 | — | — | CN | disclosed |
| EP-1406922-B1 | PROTECTION, RESTORATION, AND ENHANCEMENT OF ERYTHROPOIETIN-RESPONSIVE CELLS, TISSUES AND ORGANS | KENNETH S WARREN INST INC (US) | 2015-12-09 | — | — | EP | disclosed |
| US-20130102530-A1 | Protection, Restoration and Enhancement of Erythropoietin-Responsive Cells, Tissues and Organs | THE KENNETH S. WARREN INSTITUTE, INC. (US) | 2013-04-25 | — | — | US | disclosed |
| US-8404226-B2 | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs | THE KENNETH S. WARREN INSTITUTE, INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-20120142589-A1 | TISSUE-PROTECTIVE CYTOKINES FOR THE PROTECTION, RESTORATION AND ENHANCEMENT OF RESPONSIVE CELLS, TISSUES AND ORGANS | THE KENNETH S. WARREN INSTITUTE, INC. | 2012-06-07 | — | — | US | disclosed |
| US-20110245169-A1 | PROTECTION, RESTORATION AND ENHANCEMENT OF ERYTHROPOIETIN RESPONSIVE CELLS, TISSUES AND ORGANS | THE KENNETH S. WARREN INSTITUTE, INC. | 2011-10-06 | — | — | US | disclosed |
| EP-2281828-A2 | Compositions comprising modified erythropoietin | The Kenneth S. Warren Institute, Inc. (US) | 2011-02-09 | — | — | EP | disclosed |
| WO-2003057839-A2 | COMPOSITIONS AND METHODS RELATING TO URINARY SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| WO-2003055982-A2 | COMPOSITIONS AND METHODS RELATING TO ENDOMETRIAL SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-07-10 | — | — | WO | disclosed |
| US-20030104988-A1 | Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs | KENNETH S. WARREN INSTITUTE, INC., THE | 2003-06-05 | — | — | US | disclosed |
| US-20030072737-A1 | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs | KENNETH S. WARREN INSTITUTE, INC., THE | 2003-04-17 | — | — | US | disclosed |
| WO-2003020900-A2 | COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020897-A2 | COMPOSITIONS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020953-A2 | COMPOSITIONS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020901-A2 | COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020934-A1 | COMPOSITIONS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |